Voxtalisib Analogue
* Required Fields.
Please complete the form below and you will get the price list in 1 minute.
* Required Fields.
Please complete the form below and we will contact you shortly.
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS No. | 1349796-36-6 | Cat. No. | BCP02276 |
Name | Voxtalisib Analogue | ||
Synonyms | Voxtalisib-Analog;PI3K-IN-1;XL765-Analog; XL 765-Analog; XL-765-Analog; SAR245409-Analog; SAR245409-Analog; SAR 245409-Analog; | ||
SMILES | COC1=CC(NC2=NC3=CC=CC=C3N=C2NS(C4=CC=C(C=C4)NC(C5=CC=C(C(OC)=C5)C)=O)(=O)=O)=CC(OC)=C1 | ||
Chemical Name | |||
Formula | C31H29N5O6S | M. Wt | 599.67 |
Purity | 98% | Storage | Store at 4-8°C |
Description | XL765 is active against class I PI3K (IC50 = 39, 113, 9 and 43 nM for p110α, β, γ and δ, respectively). XL765 also inhibits DNA-PK (IC50 = 150 nM) and mTOR (IC50 = 157 nM) but not XL-147 which shows IC50 values of > 15 μM. XL765 treatment results in decreased cell viability in 13 PDA cell lines in a dose-dependent manner. XL765, a dual-target PI3K/mTOR inhibitor, inhibits cell growth and apoptosis in many more cell lines and at lower concentrations as compared to the PI3K-selective inhibitors XL147 and PIK90. The effect can be recapitulated by using combinations of single-targeted compounds. XL765 significantly reduces phosphorylation of the mTOR targets S6, S6K, and 4EBP1, which is associated with greater apoptosis induction rather than to PI3K inhibition alone. XL765 treatment causes accumulation of autophagosomes in MIAPaCa-2 cells, and results in significant dose-dependent AVO induction and LC3-II stimulation in MIAPaCa-2 cells stably expressing a LC3-GFP construct. |
Recommend Products
More >-
-
PI3K/mTOR Inhibitor-2
Cat. No.:BCP48401
No.:1848242-58-9
Product Details -
-
Disitertide
Cat. No.:BCP46789
No.:272105-42-7
Product Details -
IHMT-PI3Kδ-372
Cat. No.:BCP46775
No.:2429889-62-1
Product Details -
Gilmelisib
Cat. No.:BCP46378
No.:1845777-61-8
Product Details -
-
ETP-45658
Cat. No.:BCP45165
No.:1198357-79-7
Product Details -
-
Panulisib
Cat. No.:BCP44105
No.:1356033-60-7
Product Details -
Parsaclisib hydrochloride
Cat. No.:BCP42656
No.:1995889-48-9
Product Details -
-
-
-
Nemiralisib
Cat. No.:BCP38658
No.:1254036-71-9
Product Details -
TGR1202 racemate
Cat. No.:BCP24685
No.:1532533-65-5
Product Details -
Umbralisib tosylate
Cat. No.:BCP24684
No.:1532533-72-4
Product Details -
Umbralisib R-enantiomer
Cat. No.:BCP24683
No.:1532533-69-9
Product Details -
Umbralisib sulfate
Cat. No.:BCP24681
No.:1532533-75-7
Product Details -
GSK2292767
Cat. No.:BCP24323
No.:1254036-66-2
Product Details
Tags:Voxtalisib Analogue supplier,Voxtalisib Analogue purchase,Voxtalisib Analogue manufacturer,Voxtalisib Analogue distributor,Voxtalisib Analogue cost,Voxtalisib Analogue buy,Voxtalisib Analogue for sale